| First Author | Leng L | Year | 2022 |
| Journal | Nat Metab | Volume | 4 |
| Issue | 10 | Pages | 1287-1305 |
| PubMed ID | 36203054 | Mgi Jnum | J:351739 |
| Mgi Id | MGI:7663152 | Doi | 10.1038/s42255-022-00643-4 |
| Citation | Leng L, et al. (2022) Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to beta-amyloid clearance. Nat Metab 4(10):1287-1305 |
| abstractText | Microglial cells consume adenosine triphosphate (ATP) during phagocytosis to clear neurotoxic beta-amyloid in Alzheimer's disease (AD). However, the contribution of energy metabolism to microglial function in AD remains unclear. Here, we demonstrate that hexokinase 2 (HK2) is elevated in microglia from an AD mouse model (5xFAD) and AD patients. Genetic deletion or pharmacological inhibition of HK2 significantly promotes microglial phagocytosis, lowers the amyloid plaque burden and attenuates cognitive impairment in male AD mice. Notably, the ATP level is dramatically increased in HK2-deficient or inactive microglia, which can be attributed to a marked upregulation in lipoprotein lipase (LPL) expression and subsequent increase in lipid metabolism. We further show that two downstream metabolites of HK2, glucose-6-phosphate and fructose-6-phosphate, can reverse HK2-deficiency-induced upregulation of LPL, thus supporting ATP production and microglial phagocytosis. Our findings uncover a crucial role for HK2 in phagocytosis through regulation of microglial energy metabolism, suggesting a potential therapeutic strategy for AD by targeting HK2. |
